Form 4 for ACTU ACTUATE THERAPEUTICS, INC.
Accepted 2026-02-13 00:00:00 ET · period of report 2026-02-13 · accession 0001683168-26-001039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-13 | 2026-02-13 | ACTU | SCHMITT DANIEL M | Pres, CEO, Dir | F - Tax | $4.33 | -121.9K | 150.2K | -45% | -$527.7K |
| D | 2026-02-13 | 2026-02-13 | ACTU | SCHMITT DANIEL M | Pres, CEO, Dir | M - OptEx | $0.00 | +272.1K | 272.1K | New | $0 |
| D | 2026-02-13 | 2026-02-13 | ACTU | SCHMITT DANIEL M | Pres, CEO, Dir | M - OptEx | $0.00 | -272.1K | 272.1K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-13 | F | D | 121,874 | $4.33 | 150,181 | D | — | — | (F1) Represents 121,874 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units ("RSUs"). (F2) Represents the closing price of Issuer's common stock on February 13, 2026. |
| 2 | Common | Common Stock | 2026-02-13 | M | A | 272,055 | $0.00 | 272,055 | D | — | — | (F3) Represents the issuance of 272,055 shares of common stock from the vesting and settlement of 272,055 RSUs, which number excludes the withholding of 121,874 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1). (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Derivative | Restricted Stock Units | 2026-02-13 | M | D | 272,055 | $0.00 | 272,056 | D | — · — to — | 272,055 Common Stock | (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. (F5) 544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vest on August 14, 2026. |